Choppiness to translate into weakness?
Updated
The gold market has been volatile in the past few days, prompting us to maintain a neutral stance in the short term. However, what caught our interest during this time was MACD trying to cross through the midpoint on the daily chart. If successful, this event will likely coincide with more weakness in gold, potentially dragging it toward the area between $1,900 and 1,910 (and eventually, maybe even lower). Besides concerning MACD, indicators like RSI and Stochastic also show bearish signs. As a result, we are growing a bit bearish on gold in the short term (though we remain bullish in the long term). It would not surprise us to see investors take profits from gold if the selloff in stocks continues. We saw this occurrence in 2022 on multiple occasions, and we think it is also a real possibility in the future. Therefore, we continue to wait for a better bargain before adding more gold to our portfolio.
Illustration 1.01
Illustration 1.01 displays the daily MACD approaching the midpoint.
Technical analysis
Daily = Slightly bearish
Weekly = Neutral
Please feel free to express your ideas and thoughts in the comment section.
DISCLAIMER: This analysis is not intended to encourage any buying or selling of any particular securities. Furthermore, it should not be a basis for taking any trade action by an individual investor. Therefore, your own due diligence is highly advised before entering a trade.
Illustration 1.01
Illustration 1.01 displays the daily MACD approaching the midpoint.
Technical analysis
Daily = Slightly bearish
Weekly = Neutral
Please feel free to express your ideas and thoughts in the comment section.
DISCLAIMER: This analysis is not intended to encourage any buying or selling of any particular securities. Furthermore, it should not be a basis for taking any trade action by an individual investor. Therefore, your own due diligence is highly advised before entering a trade.
Note
Gold is testing the support at $1,910.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.